Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Advanz Pharma
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
18-85 years old,
Stable NYHA Class III-IV
Hospitalization or ER visits in past 18 months for worsening Heart Failure (or addition of new heart failure medication added to regimen due to lack of stability on current regimen.
EF =\< 40%
You may not be if
Any condition (other than CHF) that could limit exercise
Any concurrent disease likely to limit life expectancy.
Participation in another clinical trial
Primary valvular disease, active myocarditis, or an obstructive or restrictive cardio-myopathy
Heart Attack, Stroke, Unstable Angina or Cardiac surgery within previous 3 months
Clareo Health | Oxypurinol Compared With Placebo for Class III-IV NYHA Congestive Heart Failure
